Immix Biopharma (IMMX) stock Forecast for 2022 – 2026
Last update: 05-24-2022, 7:07
Sector: HealthcareThe share price of Immix Biopharma, Inc. (IMMX) now
What analysts predict:: $None
52-week high/low: $7.9 / $1.25
50/200 Day Moving Average: $1.799 / $3.007
This figure corresponds to the average price over the previous 50/200 days. For Immix Biopharma stocks, the 50-day moving average is the support level today.
For Immix Biopharma stocks, the 200-day moving average is the resistance level today.
Are you interested in Immix Biopharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Immix Biopharma stock price in 2022, 2023, 2024, 2025, 2026. How much will one Immix Biopharma share be worth in 2022 - 2026?
When should I take profit in Immix Biopharma stock? When should I record a loss on Immix Biopharma stock? What are analysts' forecasts for Immix Biopharma stock? What is the future of Immix Biopharma stock?
We forecast Immix Biopharma stock performance using neural networks based on historical data on Immix Biopharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Immix Biopharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Immix Biopharma shares. This happens once a day.
Historical and forecast chart of Immix Biopharma stock
The chart below shows the historical price of Immix Biopharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Immix Biopharma stock price can be found in the table below.
Long-term forecasts by years.
Immix Biopharma daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 26 | 2.13 | 2.09 | 2.18 | 4.21 |
| May 27 | 2.07 | 2.00 | 2.13 | 6.39 |
| May 28 | 2.09 | 2.01 | 2.13 | 5.99 |
| May 29 | 1.99 | 1.90 | 2.02 | 6.66 |
| May 30 | 1.97 | 1.88 | 2.02 | 7.48 |
| May 31 | 1.93 | 1.86 | 1.97 | 6.04 |
| Jun 01 | 1.91 | 1.83 | 2.00 | 9.05 |
| Jun 02 | 1.96 | 1.90 | 2.05 | 7.79 |
| Jun 03 | 1.87 | 1.80 | 1.91 | 6.41 |
| Jun 04 | 1.82 | 1.77 | 1.87 | 5.68 |
| Jun 05 | 1.76 | 1.72 | 1.79 | 4.11 |
| Jun 06 | 1.80 | 1.76 | 1.83 | 4.12 |
| Jun 07 | 1.77 | 1.72 | 1.85 | 7.78 |
| Jun 08 | 1.75 | 1.72 | 1.83 | 6.86 |
| Jun 09 | 1.78 | 1.76 | 1.85 | 5.34 |
| Jun 10 | 1.86 | 1.79 | 1.91 | 6.95 |
| Jun 11 | 1.87 | 1.84 | 1.90 | 3.29 |
| Jun 12 | 1.91 | 1.83 | 1.97 | 7.38 |
| Jun 13 | 1.85 | 1.83 | 1.88 | 3.10 |
| Jun 14 | 1.82 | 1.77 | 1.87 | 5.85 |
| Jun 15 | 1.78 | 1.75 | 1.85 | 5.99 |
| Jun 16 | 1.69 | 1.63 | 1.73 | 6.61 |
| Jun 17 | 1.75 | 1.69 | 1.77 | 5.16 |
| Jun 18 | 1.71 | 1.64 | 1.74 | 5.83 |
| Jun 19 | 1.81 | 1.73 | 1.85 | 7.10 |
| Jun 20 | 1.79 | 1.77 | 1.85 | 4.75 |
| Jun 21 | 1.82 | 1.74 | 1.85 | 6.31 |
| Jun 22 | 1.82 | 1.78 | 1.87 | 5.01 |
| Jun 23 | 1.82 | 1.78 | 1.84 | 3.43 |
| Jun 24 | 1.74 | 1.71 | 1.76 | 3.11 |
Immix Biopharma Daily Price Targets
Immix Biopharma Stock Forecast 05-26-2022.
Pessimistic target level: 2.09
Optimistic target level: 2.18
Immix Biopharma Stock Forecast 05-27-2022.
Pessimistic target level: 2.00
Optimistic target level: 2.13
Immix Biopharma Stock Forecast 05-28-2022.
Pessimistic target level: 2.01
Optimistic target level: 2.13
Immix Biopharma Stock Forecast 05-29-2022.
Pessimistic target level: 1.90
Optimistic target level: 2.02
Immix Biopharma Stock Forecast 05-30-2022.
Pessimistic target level: 1.88
Optimistic target level: 2.02
Immix Biopharma Stock Forecast 05-31-2022.
Pessimistic target level: 1.86
Optimistic target level: 1.97
IMMX (IMMX) Monthly Stock Prediction for 2022
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 2.48 | 2.34 | 2.80 | 16.35 |
| Jul. | 2.73 | 2.60 | 3.10 | 16.29 |
| Aug. | 2.59 | 2.48 | 2.87 | 13.79 |
| Sep. | 2.10 | 1.77 | 2.39 | 25.96 |
| Oct. | 2.18 | 2.05 | 2.29 | 10.40 |
| Nov. | 2.57 | 2.41 | 2.77 | 13.03 |
| Dec. | 2.41 | 2.26 | 2.75 | 17.89 |
Immix Biopharma forecast for this year
Immix Biopharma Stock Prediction for Jun 2022
An uptrend is forecast for this month with an optimal target price of $2.47508. Pessimistic: $2.34. Optimistic: $2.80
Immix Biopharma Stock Prediction for Jul 2022
An uptrend is forecast for this month with an optimal target price of $2.73496. Pessimistic: $2.60. Optimistic: $3.10
Immix Biopharma Stock Prediction for Aug 2022
An downtrend is forecast for this month with an optimal target price of $2.58563. Pessimistic: $2.48. Optimistic: $2.87
Immix Biopharma Stock Prediction for Sep 2022
An downtrend is forecast for this month with an optimal target price of $2.09695. Pessimistic: $1.77. Optimistic: $2.39
Immix Biopharma Stock Prediction for Oct 2022
An uptrend is forecast for this month with an optimal target price of $2.18062. Pessimistic: $2.05. Optimistic: $2.29
Immix Biopharma Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $2.56986. Pessimistic: $2.41. Optimistic: $2.77
Immix Biopharma Stock Prediction for Dec 2022
An downtrend is forecast for this month with an optimal target price of $2.41335. Pessimistic: $2.26. Optimistic: $2.75
Immix Biopharma (IMMX) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.41 | 2.17 | 2.74 | 20.88 |
| Feb | 2.41 | 2.02 | 2.65 | 23.66 |
| Mar | 2.83 | 2.44 | 3.29 | 25.67 |
| Apr | 2.36 | 2.12 | 2.61 | 18.62 |
| May | 2.51 | 2.35 | 2.67 | 11.66 |
| Jun | 2.94 | 2.53 | 3.19 | 20.58 |
| Jul | 3.28 | 3.10 | 3.71 | 16.35 |
| Aug | 2.97 | 2.61 | 3.10 | 15.69 |
| Sep | 3.31 | 3.10 | 3.85 | 19.63 |
| Oct | 3.85 | 3.56 | 4.09 | 12.87 |
| Nov | 4.48 | 4.18 | 4.80 | 12.94 |
| Dec | 4.03 | 3.55 | 4.19 | 15.32 |
Immix Biopharma (IMMX) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 4.08 | 3.81 | 4.52 | 15.74 |
| Feb | 4.02 | 3.63 | 4.20 | 13.68 |
| Mar | 4.32 | 3.88 | 5.04 | 22.88 |
| Apr | 4.66 | 4.11 | 5.16 | 20.45 |
| May | 5.22 | 4.85 | 5.88 | 17.53 |
| Jun | 5.33 | 4.49 | 5.83 | 22.88 |
| Jul | 4.90 | 4.61 | 5.39 | 14.50 |
| Aug | 5.80 | 5.08 | 6.59 | 22.91 |
| Sep | 4.64 | 4.20 | 4.99 | 15.81 |
| Oct | 4.01 | 3.39 | 4.51 | 24.85 |
| Nov | 4.36 | 4.14 | 4.71 | 12.03 |
| Dec | 4.13 | 3.55 | 4.80 | 26.16 |
Immix Biopharma (IMMX) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 4.65 | 4.41 | 4.96 | 11.02 |
| Feb | 4.77 | 4.47 | 5.51 | 18.90 |
| Mar | 4.64 | 3.97 | 4.89 | 18.76 |
| Apr | 4.92 | 4.10 | 5.29 | 22.45 |
| May | 5.15 | 4.59 | 5.76 | 20.29 |
| Jun | 4.88 | 4.49 | 5.28 | 14.95 |
| Jul | 5.16 | 4.41 | 5.59 | 21.12 |
| Aug | 5.87 | 5.23 | 6.13 | 14.68 |
| Sep | 6.38 | 5.56 | 7.14 | 22.13 |
| Oct | 6.86 | 6.32 | 7.93 | 20.36 |
| Nov | 7.06 | 6.77 | 7.73 | 12.47 |
| Dec | 7.21 | 6.88 | 7.71 | 10.80 |
Immix Biopharma (IMMX) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 8.33 | 7.81 | 9.23 | 15.36 |
| Feb | 8.58 | 7.88 | 9.86 | 20.10 |
| Mar | 9.97 | 9.21 | 11.43 | 19.41 |
| Apr | 10.91 | 9.10 | 11.78 | 22.75 |
| May | 11.16 | 10.57 | 12.47 | 15.22 |
| Jun | 12.68 | 11.86 | 14.65 | 19.08 |
| Jul | 14.47 | 13.22 | 16.35 | 19.14 |
| Aug | 16.05 | 14.60 | 18.64 | 21.69 |
| Sep | 17.33 | 15.95 | 18.42 | 13.43 |
| Oct | 16.27 | 15.01 | 17.85 | 15.90 |
| Nov | 13.95 | 11.61 | 14.68 | 20.95 |
| Dec | 11.78 | 11.21 | 13.51 | 17.03 |
Immix Biopharma information and performance
Immix Biopharma is a United States-based clinical stage biopharmaceutical company with a division in Australia (Immix Biopharma Australia).
Immix Biopharma conducts research in the treatment of cancer and inflammatory diseases. The company’s key experimental line, IMX-110, is in phase 1b / 2a clinical trials and is being investigated for efficacy in the treatment of solid tumors. Tests are taking place in the United States and Australia.
Immix Biopharma Address
11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES, CA, UNITED STATES
Market Capitalization: 29 436 200 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: - $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
DPS: N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: -3.929
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: -
Enterprise Value (EV) /Revenue
EV To EBITDA: -
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 13885000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A